NT 10-Q

ENDV NT 10-Q 03/31/15

Company: ENDONOVO THERAPEUTICS, INC.
Filed: May 15, 2015
Period of Report: March 31, 2015
Accession Number: 0001469709-15-000260

View Document ↗ View on SEC.gov ↗